Skip to main content
Adicet Bio, Inc. (ACET)
NASDAQ: ACET · Real-Time Price · USD
2.780
-0.150 (-5.12%)
Nov 13, 2026, 4:00 PM EST - Market closed

Adicet Bio Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
----24.999.73
Revenue Growth
----156.83%-45.65%
Gross Profit
----24.999.73
Selling, General & Admin
18.9622.9928.2926.5326.322.22
Research & Development
76.699.1399.32106.0471.2547.75
Operating Expenses
95.55122.11127.62132.5897.5469.97
Operating Income
-95.55-122.11-127.62-132.58-72.55-60.24
Interest Expense
-0.09-0.04-0-0.03-0.08-0.18
Interest & Investment Income
5.015.7810.719.983.760.09
Other Non Operating Income (Expenses)
-0.21-0.43-0.22-0.57-0.92-0.61
EBT Excluding Unusual Items
-90.85-116.8-117.12-123.2-69.79-60.93
Impairment of Goodwill
----19.46--
Asset Writedown
------1.19
Pretax Income
-90.85-116.8-117.12-142.66-69.79-62.12
Income Tax Expense
0.14-----0.13
Net Income
-91-116.8-117.12-142.66-69.79-62
Net Income to Common
-91-116.8-117.12-142.66-69.79-62
Net Income Growth
------
Shares Outstanding (Basic)
1175332
Shares Outstanding (Diluted)
1175332
Shares Change
87.06%25.49%104.14%4.78%32.72%322.85%
EPS (Basic)
-8.53-16.95-21.33-53.03-27.18-32.05
EPS (Diluted)
-8.53-16.95-21.33-53.03-27.18-32.05
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-80.43-96.98-93.5-98.18-61.55-64.1
Free Cash Flow Per Share
-7.54-14.07-17.02-36.50-23.97-33.13
Gross Margin
----100.00%100.00%
Operating Margin
-----290.32%-619.15%
Profit Margin
-----279.27%-637.19%
Free Cash Flow Margin
-----246.29%-658.77%
EBITDA
-90.5-115.73-121.15-126.48-69.98-58.71
EBITDA Margin
-----280.02%-
D&A For EBITDA
5.056.386.476.12.581.54
EBIT
-95.55-122.11-127.62-132.58-72.55-60.24
EBIT Margin
-----290.32%-
SEC Filings: 10-K · 10-Q